< Back to latest news & events

Event

Webinar: Developing effective patent strategies for personalised medical devices in Europe and the US

May 2021

Event date: 9th June 2021

HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June.

In this webinar we will explore considerations for implementing an effective strategy to secure patent protection for personalised medical devices, and to steer through a potentially crowded competitive landscape, with a particular focus on comparing the European and US jurisdictions.

The emergence of new platform technologies directed to patient-specific healthcare solutions has led to significant investment and R&D associated with personalised medical devices. In order to protect their technological innovations, many companies are striving to strategically develop global patent portfolios that support the commercialisation of their products and which can leverage a dominant commercial position over competitors. As national and regional differences exist between legal provisions that govern intellectual property, it is not always possible to adopt a “one-size-fits-all” approach. A more thorough understanding of these differences is therefore vital when seeking to maximise the scope of protection available to the patent proprietor or to minimise patent infringement risk when commercialising personalised medical devices.

This webinar will cover:

  • an overview of the growth in patent applications for personalised medical devices and examples of patent claims that can protect them;
  • considerations for drafting and prosecuting patent applications directed to personalised medical devices and how these approaches differ between Europe and the US;
  • a case study examining litigation, in the US, of a patent portfolio with claims covering personalised medical devices and how defendants challenged patent validity.

Speakers

Dr Adam Hines, HGF

Christy Lea, Knobbe Martens

Sabing Lee, Knobbe Martens

Date

9th June

Time

4.00 pm (BST)

8.00 am (PT)

10.00 am (CT)

11.00 am (ET)

Attendees

Latest updates

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

T1977/22: Can claims defined by open-ended ranges ever be sufficiently disclosed?

The EPO’s Board of Appeal’s decision in T1977/22 provides an interesting review of the case law concerning the compatibility of whole range sufficiency and claims defined as a result to …

Read article

The draft of The Genetic Technology (Precision Breeding) Regulations 2025 reveals practical details on how to obtain a Precision Bred Organism status

In a recent blog post we discussed the Precision Breeding Regulatory Framework developed by the Food Standards Agency (FSA). Further details on the application process for Precision Bred Organism confirmation …

Read article

A £2.1M Lesson: The Power of Confidential Information

A recent High Court ruling1 serves as a stark reminder of the importance of respecting confidential business information. Hambro Perks, was found guilty of breaching confidentiality and ordered to pay …

Read article
Event - 6th March 2025

IQPC Global IP Exchange Europe 2025

HGF is sponsoring the IQPC Global IP Exchange Europe, which will be held on the 11th-12th March 2025 in Meliá, Berlin. Head of Electronics, Chris Benson, will be chairing the …

Event details

IP Ingredients: Pouring Over the Verdict: What Thatchers v Aldi Means for Food & Drink Brands

Readers of our IP Ingredients blog may recall that we covered something of this case last summer in our post IP Ingredients: Summer case law review. The dispute between Thatchers …

Read article

Protecting inventions in Europe and beyond

A patent is  a form of registered intellectual property right granted for new, inventive and industrially applicable inventions. Patents are monopoly rights that  allow their owners (or licensees) the right …

Read article